Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share
Go back to Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share| Merck & Co. (NYSE: MRK) | Delayed: 115.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.48 | 52 Week High | $65.46 | |||
| Open | $115.48 | 52 Week Low | $47.97 | |||
| Day High | $115.48 | P/E | 78.56 | |||
| Day Low | $115.48 | EPS | $1.47 | |||
| Volume | 12,902 | |||||
| (NASDAQ: TERN) | Delayed: 52.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.95 | 52 Week High | $ | |||
| Open | $52.95 | 52 Week Low | $ | |||
| Day High | $52.95 | P/E | N/A | |||
| Day Low | $52.95 | EPS | $ | |||
| Volume | 1 | |||||

